Capital Cell
Funding platformBarcelona · Pre-Seed–Growth
Find your way into Capital Cell
Investment thesis
Capital Cell operates an equity crowdfunding-style investment platform dedicated to biotechnology and life sciences. It curates opportunities through the BioExpert Network, an independent community of more than 3,500 experts in life sciences, health, biotech, and medicine, admitting only about 3% of companies that apply. Each selected company is chosen for its potential to scale globally and deliver strong returns, allowing investors to co-invest alongside leading scientific, investment, and social-impact institutions while making an impact on the future of global health.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 37 of 67 portfolio companiesMedical Devices ×30Healthtech ×27Biotech ×22Digital Health ×15Deep Tech ×9AI & Machine Learning ×8Hardware ×4Wellness & Fitness ×4
HQs:Spain×17France×3Switzerland×2United Kingdom×1United States×1
Who they back
founder profiles across 18 portfolio companiesFounding team size:solo founder×82 founders×53 founders×44+ founders×1
Where their founders studiedfrom 22 founders with education data
Universitat Politècnica de Catalunya ×5Esade ×3Universitat Autònoma de Barcelona ×3Universitat de Barcelona ×2University of Buenos Aires ×2
What their founders studiedfrom 23 founders with field-of-study data
Life Sciences ×9Engineering ×6Business & Management ×3Computer Science ×2Mathematics & Statistics ×2Physics ×2
Where their founders worked beforefrom 24 founders with career history
Universitat de Barcelona ×3CIMNE ×2CSIC ×2Harvard Medical School ×2
14 founders hold a PhD · 4 hold an MBA (of 24 with degree data)
Investments · 67 tracked
founders shown can be your intro pathAntalgenics develops drugs and neurocosmetical products targeting dermatological and inflammatory conditions such as psoriatic pruritus, arthritic pain, and sensitive skin.
BiotechDeep TechHealthtechMedical DevicesWellness & FitnessElche, ES
AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs.
BiotechDigital HealthHealthtechMedical DevicesGirona, ES
Carles Domenech(Founder)in
Co-investorsCTI Life Sciences Fund L.P.Inveready Technology Investment Group
Airway Shield develops a patented protective device used during endotracheal intubation to reduce dental trauma, patient complications, and infection risk to clinicians.
HardwareHealthtechMedical Devices
Amadix develops blood-based diagnostic tests for early cancer detection before symptoms appear.
AI & Machine LearningBiotechDigital HealthMedical Devices
Rocio Arroyo(Founder)in
Co-investorsDozen InvestmentsCRB Inverbío
Biointaxis is an academic biotech spin-off developing a gene therapy to restore the function of a defective protein in patients with Friedreich's ataxia, a rare inherited neurodegenerative disease.
BiotechHealthtechMedical DevicesBadalona, ES
Antoni Matilla Dueñas(CEO & Co-Founder)inIvelisse Sánchez(CSO & Co-Founder)inJaime Melendo(Board Member & Co-Founder)Daniel Pérez(Chief Financial Officer)
Bionure Investment is a company based in Barcelona focused on developing solutions for neurodegenerative diseases affecting patients worldwide.
BiotechDeep TechDigital HealthHealthtechMedical DevicesBarcelona, ES
Carmen Sanfrancisco(Consejera Delegada (Board Member))inPere Monràs(President)inSalut Monràs(Former President)in
Braingaze develops BGaze Clinic, a digital health platform for diagnosing, treating, and monitoring cognitive disorders using eye-movement tracking and biomarker analysis.
AI & Machine LearningDigital HealthMedical DevicesLondon, GB
Laszlo Bax(Co-founder & CEO)inProf. Hans Supèr(Co-founder & CTO)
Corify develops ACORYS, a cardiac mapping system for clinicians that performs real-time, beat-to-beat global cardiac mapping to help diagnose cardiac arrhythmias.
HealthtechMedical Devices
Andreu M. Climent(Founder)in
Cuideo is a platform that connects families with screened home care professionals for elderly and dependent relatives in Spain.
B2B MarketplacesHealthtechBarcelona, ES
Co-investorsDozen InvestmentsInderhabsMundi Ventures
Dermavision Solutions builds Deviskan, an automated device that combines total body mapping and digital dermoscopy to capture full-body clinical images and support dermatologists in patient monitoring and early melanoma detection.
Digital HealthHealthtechMedical Devices
EnricNarcís
Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections.
ConsumerHealthtechWellness & Fitness
Co-investorsCriteria Bio VenturesEmesa Corporación EmpresarialShip2BEuropean Investment Fund
ELEM develops healthcare digital twins using biosimulation technology to enable pharmaceutical and medical device companies to test and predict treatment outcomes before clinical trials.
AI & Machine LearningBiotechDeep TechDigital HealthMedical Devices
Christopher Morton(Founder)inMariano Vázquez(Co-Founder)inGuillaume Houzeaux(Co-Founder)in
Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite.
BiotechLongevityMedical Devices
Giacomo de Simone(CEO)David M. Selva(CSO)Rafael Simó(CMO)Agustí Soler(CFO)
EVerZom develops exosome formulation technologies that modify cells to release exosomes with enhanced therapeutic properties, designed for targeted delivery to specific tissue sites.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Fecundis is a biotechnology company developing sperm-centered technologies for assisted reproduction, including HyperSperm, a sequential-step kit that recreates physiological sperm capacitation in vitro for IVF and ICSI.
BiotechFemTechHealthtech
Mariano Buffone(Co-founder & CSO)inDario Krapf(Co-founder & CSO)inArina Rogozina(CEO)inMatías Gómez Elías(COO)in
Co-investorsGRIDX
Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics.
AI & Machine LearningBiotechDigital HealthMedical Devices
João Curado(CEO & Co-founder)inEsther Lizano(Scientific Advisor & Co-founder)Luís Korrodi(Business Advisor & Co-founder)inAndré Guedes(COO & Co-founder)in
mediQuo operates an omnichannel telemedicine platform with its own medical team of over 300 professionals across 22+ specialties, offering patients chat, calls, scheduled and on-demand video consultations, online appointments, e-prescriptions, and AI-generated medical reports.
AI & Machine LearningDigital HealthHealthtech
Co-investorsDozen InvestmentsTarget Global
mjn develops neurological monitoring technology solutions for patients with epilepsy and other neurological disorders.
AI & Machine LearningHealthtechMedical Devices
Co-investorsShip2B
MOWOOT is a non-invasive medical device that delivers Intermittent Colonic Exoperistalsis (ICE), applying gentle sequential abdominal pressure inspired by clinical abdominal massage to support bowel movement in people with chronic constipation.
Digital HealthHealthtechMedical Devices
Immaculada Herrero Fresneda, PhD.(Founder)in
Co-investorsMonte Carlo CapitalShip2B
Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications.
BiotechDeep TechMedical Devices
Nexkin Medical designs and manufactures medical devices and systems for allergology testing.
Digital HealthHealthtechMedical Devices
Nuubo offers a wireless, non-invasive cardiac monitoring technology (aECG) based on textile electrodes for medium- and long-term remote heart monitoring.
Digital HealthHardwareMedical Devices
Co-investorsCriteria Bio VenturesFides Capital
ONASPORT is a wearable device that monitors athletic performance through non-invasive analysis of sweat-based biomarkers including lactate, sodium, dehydration, and electrolyte loss.
BiotechDigital HealthHardwareHealthtechIoTMedical DevicesSports TechBarcelona, ES
Elisabet del Valle(CEO & Co-Founder)inXavier Muñoz(CSO & Co-Founder)
Oncostellae is a biotech company developing novel JAK inhibitors for the treatment of inflammatory bowel disease and cancer, with a focus on local, gut-restricted therapies that minimize systemic toxicity.
BiotechHealthtechMedical DevicesGalicia, ES
Open Stent Solution develops a percutaneous medical device for mitral and tricuspid valve replacement in cardiac patients ineligible for open-heart surgery.
BiotechDeep TechHealthtechMedical DevicesUnknown from page, FR
Co-investorsAngels Santé
Ownmed Innovation is a spin-off that develops medical devices and technologies to address unmet clinical needs, taking products through preclinical studies, clinical trials, and CE certification under EU regulation 2017/745.
BiotechHealthtechMedical Devices
OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients.
HardwareHealthtechMedical Devices
Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds.
AI & Machine LearningBiotechDeep TechBarcelona, ES
Enric Gibert(Founder)inEnric Herrero(Founder)in
Co-investorsGENERAL INCEPTIONHeran Partners
StimuSIL is a medical device company developing subdermal photobiomodulation technology that uses patented methods to deliver light-based stimulation beneath the skin's melanin layer for dermatology and aesthetics indications.
BiotechHealthtechMedical DevicesWellness & FitnessWilmington, US
Ana Isabel Villalba Villar(Founder)inAna Villalba(Founder & Chief Executive Officer)inAna Villalba Villar(Executive Officer, Director)inPablo Villalba(Founder & Chairman)inFirat Yerlikaya(Director)
BoardAbidin Gulmus(Director)
The Sampling Solutions (TSS) plans, executes, and digitizes water sampling, inspections, and audits across Spain using a network of ISO 17025-qualified field technicians.
CleantechClimate TechSaaS
Carlos Arias(Founder)in
Time is Brain develops BraiN20®, a real-time brain monitoring device for stroke patients that provides bedside neurological data to guide treatment decisions during time-critical interventions.
Deep TechHealthtechMedical DevicesBarcelona, ES
Dr. Alicia Martínez(Co-founder)Dr. Antoni Dávalos(Co-founder)Dr. Jaume Coll(Co-founder)
Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally.
BiotechDeep TechHealthtechMedical Devices
Petter Björquist(Chief Executive Officer)inRaimund Strehl(Chief Technology Officer)inEdvard Nordfors(Chief Financial Officer)in
Co-investorsScientia Ventures
Vytrus is a biotechnology company focused on plant-based science and product development.
AgTechBiotechConsumerHealthtechWellness & FitnessSpain, ES
Òscar Expósito(CEO, CSO & co-founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
24 GeneticsAdan Medical InnovationAhead TherapeuticsAortyxArjuna TherapeuticsBioprognosCornea ProjectEktaHExheusFastbaseFesia TechnologyFrontwave ImagingGenomcore (Made of Genes)HCS PharmaIDP PharmaINROBICS SOCIAL ROBOTICSKintsugi TherapeuticsLaminar PharmaceuticalsLeadartisLumirisMethinksMSInsightOxolifeRheo DiagnosticsRUTI ImmuneTech4FreedomTerapTractivusVB DevicesZeCardio
Portfolio news
latest coverage across their companiesPharmacelera · ddw-online.com · Feb 20, 2026
Frequently asked questions
- How many investments has Capital Cell made?
- Capital Cell has 67 tracked investments.
- What stage does Capital Cell invest at?
- Capital Cell invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Capital Cell focus on?
- Capital Cell focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Capital Cell located?
- Capital Cell is headquartered in Barcelona, ES.
- Who does Capital Cell co-invest with?
- Capital Cell most often shares deals with Ship2B, Dozen Investments, BStartup, among 16 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.